Addition of High-Dose Cytarabine to Immunochemotherapy before Autologous Stem-Cell Transplantation in Patients Aged 65 Years or Younger with Mantle Cell Lymphoma (MCL Younger): A Long-Term Follow-up of the Randomized, Open-Label, Phase 3 Trial of the European Mantle Cell Lymphoma Network
Blood（2021）
摘要
On Behalf of the European Mantle Cell Lymphoma Network
更多查看译文
关键词
mantle stem-cell lymphoma,immunochemotherapy,transplantation,high-dose,long-term,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要